The higher expression of FZD6 correlated to a much worse overall survival time in all grade gliomas (p < 0.0001; Figure 6F), especially grade III glioma (p = 0.0092, Figure 6G) and grade IV GBs (p = 0.00072, Figure 6H). This evidence concerns the gene FZD6 and central nervous system cancer.